**Specifications Table** *\[please fill in right-hand column of the table below\]*TableSubject area*Biochemistry, Virology*More specific subject area*NMR structural analysis*Type of data*Figures, Table*How data was acquired*The NMR data were acquired on a Bruker AvanceIII 800 MHz spectrometer equipped with a 5 mm TXI (*^*1*^*H/*^*13*^*C/*^*15*^*N/*^*2*^*H) probe. The CD data were acquired with a Jobin Yvon-SPEX-Horiba model CD6 spectropolarimeter.*Data format*Analyzed*Experimental factors*The NS5A-D2 samples were prepared as described by Hanoulle et al.*[@bib12]*and have been in vitro phosphorylated by CKII.*Experimental features*Solution state NMR experiments (2D and 3D) were acquired at 298 K on a 250 µM*^*15*^*N,*^*13*^*C-labeled-NS5A-D2_CKII sample in 20 mM sodium phosphate buffer (pH 6.4), 30 mM NaCl, 1 mM THP, 0.02% NaN*~*3*~*and 5% D*~*2*~*O. Proton chemical shifts were referenced using the methyl signal of sodium 3-trimethylsilyl-\[2,2,3,3-d4\]propionate at 0* *ppm.CD data were collected at 293 K on an unlabeled NS5A-D2_CKII sample (6.4 µM) in 10 mM sodium phosphate buffer (pH 6.4), 10 mM NaCl.*Data source location*Villeneuve d'Ascq, France, GPS: 50° 36' 16.156" N; 3° 8' 45.315" E*Data accessibility*Data are available with this article and NMR data are accessible in the Biological Magnetic Resonance data Bank (BMRB) under accession number*[27270](mgi:27270){#ir0010}. *BMRB ID:*[27270](mgi:27270){#ir0015}*.*[http://www.bmrb.wisc.edu/data_library/summary/?bmrbId=27270](http://http://www.bmrb.wisc.edu/data_library/summary/?bmrbId=27270){#ir0020}

**Value of the data**•The data showing that NS5A-D2 is phosphorylated by CKII on S288 may be useful to others researchers who study phosphorylation of the HCV NS5A protein.•The ^1^H, ^15^N and ^13^C NMR chemical shift assignments of NS5A-D2 phosphorylated by CKII could be valuable for spectroscopists working on other phosphorylated NS5A-D2 samples and to establish comparisons.•The CD and the ^13^Cα and ^13^Cβ chemical shifts data may be used to extract structural information, which could then be used in structure-function studies.

1. Data {#s0005}
=======

We expressed the intrinsically disordered domain 2 (residues 248-341) [@bib3], [@bib4], [@bib5] of the HCV NS5A protein [@bib1], [@bib2], which is required for viral replication [@bib6], [@bib7], in *Escherichia coli* and purified it as described in Hanoulle et al. [@bib12]. Subsequently, the NS5A-D2 was *in vitro* phosphorylated by CKII ([Fig. 1](#f0005){ref-type="fig"}) [@bib8], [@bib9], [@bib10], [@bib11]. The resulting NS5A-D2_CKII sample was then analyzed by circular dichroism spectroscopy ([Fig. 2](#f0010){ref-type="fig"}) and by NMR spectroscopy. [Table 1](#t0005){ref-type="table"} lists the ^1^H, ^15^N and ^13^C chemical shift assignments of NS5A-D2_CKII. The annotated ^1^H-^15^N HSQC spectrum of NS5A-D2_CKII is displayed in [Fig. 3](#f0015){ref-type="fig"}. Chemical shift perturbations induced by the phosphorylation on S288 are illustrated in [Fig. 4](#f0020){ref-type="fig"}, and finally, the secondary structure propensity (SSP) scores are displayed in [Fig. 5](#f0025){ref-type="fig"}.Fig. 1Phosphorylation of NS5A-D2 by CKII. Domain 2 of the HCV NS5A protein (NS5A-D2), expressed in *E. coli* and purified, was analyzed by 15% SDS--PAGE and stained with Coomassie blue before and after *in vitro* phosphorylation by CKII.Fig. 1Fig. 2Far-UV circular dichroism analysis of NS5A-D2_CKII and comparison with NS5A-D2. The CD spectra of NS5A-D2_CKII (solid line) and NS5A-D2 (dashed line) were recorded in 10 mM sodium phosphate buffer (pH 6.4), 10 mM NaCl.Fig. 2Fig. 3^1^H,^15^N-HSQC NMR spectrum of NS5A-D2_CKII. The spectrum has been acquired using an 800 MHz spectrometer on a 250 µM sample. Amide proton assignments listed in [Table 1](#t0005){ref-type="table"} are shown on the spectrum.Fig. 3Fig. 4^1^H,^15^N combined chemical shift perturbations induced in NS5A-D2 by phosphorylation of S288. The CSP value of 0.324 ppm for S288 is higher than the upper limit of the graph and has thus been labeled.Fig. 4Fig. 5Secondary structure propensity analysis of ^13^Cα and ^13^Cβ NMR chemical shifts of NS5A-D2_CKII. Values close to 0 correspond to fully disordered residues, whereas positive and negative scores represent helical propensities and extended regions, respectively [@bib18]. The SSP scores of NS5A-D2_CKII (in red) are compared with those of unphosphorylated NS5A-D2 (in blue). The position of the pS288 residue in NS5A-D2_CKII is highlighted by an asterisk.Fig. 5Table 1HCV NS5A-D2_CKII NMR chemical shift assignments (BMRB ID: [27270](mgi:27270){#ir0005}).Table 1**ResidueAAHNNCαCβC\'**248N53.2339.06175.07249T8.24114.6662.2369.62174.13250Y8.10121.0957.7338.65175.39251D8.20122.0554.5841.25176.27252V7.98119.3362.6732.74175.89253D8.36122.4954.8241.05176.27254M8.15120.7555.5132.73176.20255V8.09121.5262.8732.63175.94256D8.36123.8854.6341.11176.49257A8.33125.4253.5618.96178.26258N8.47116.4753.9438.49175.73259L7.92121.2955.8942.11177.60260L7.98121.4355.1641.95177.43261M8.14120.4655.5632.77176.45262E8.40122.0856.9930.16177.10263G8.48110.2245.38.174.76264G8.26108.6144.98.173.97265V7.98119.0462.0932.91175.92266A8.44127.9752.3419.12177.60267Q8.43120.3155.8429.51176.07268T8.21115.7561.8370.00174.36269E8.49124.6254.5929.57174.68270P63.4632.00177.08271E8.58120.8256.9430.08176.66272S8.33116.8858.4163.76174.40273R8.37123.5255.9930.81176.02274V8.18123.1960.1532.45174.47275P63.2932.08176.54276V8.21121.0162.5432.39176.13277L8.31126.3754.8942.46176.70278D8.17121.0254.3441.19175.57279F8.03119.8257.6439.46175.08280L8.06124.3854.7142.65176.49281E8.24123.5854.3329.64174.38282P63.1332.03176.90283M8.46121.0855.2533.20175.92284A8.39126.0852.3519.40177.55285E8.46120.6656.4030.40176.38286E8.46122.0156.2430.68176.31287E8.51122.6256.8630.70176.62288pS8.82118.0657.8066.18173.90289D8.50122.2454.5341.00175.89290L8.12122.3355.1442.66177.32291E8.36123.0454.4229.58174.41292P63.0332.09176.96293S8.45116.4658.4863.99174.25294I8.13123.7559.1338.77174.60295P63.5832.09177.22296S8.39116.2059.0663.78175.24297E8.63122.0857.2929.77176.59298C8.21118.8458.9627.88174.48299M8.28122.2555.3732.58175.80300L8.10124.2553.2141.75175.04301P63.2232.00177.08302R8.51121.4056.2730.66176.59303S8.33116.2958.7963.92174.88304G8.37110.3445.00.173.39305F8.03120.6855.8739.08173.39306P63.3731.94176.64307R8.34121.1856.1530.92175.87308A8.28124.7852.0219.27177.14309L8.10122.9652.7142.09175.09310P62.7731.70177.16311A8.46123.3054.0818.69178.06312W7.17113.8956.3228.58175.88313A7.45124.4751.9219.30176.73314R7.76120.4154.2930.42174.85315P63.9731.81176.47316D8.31117.7353.8040.39175.61317Y7.82120.6958.1038.97174.82318N8.18123.8850.7239.41171.55319P320P62.9931.86176.78321L8.24122.1655.2542.09177.39322V8.02120.9262.3932.76176.07323E8.57124.4756.7029.71176.99324S8.33116.8959.4363.60174.42325W7.69120.7257.1428.87175.90326R7.57122.1155.9030.75175.49327R8.07123.0354.2330.21174.83328P63.8331.85176.56329D8.35118.2353.9840.55175.75330Y7.87120.6158.4038.97174.91331Q7.90125.6252.4329.66172.37332P333P63.1631.99176.99334T8.19114.4161.8169.95174.60335V8.16122.5662.1632.89175.78336A8.44127.9552.7419.11178.22337G8.40108.3145.29.174.08338C8.12118.6958.3228.26174.05339A8.43126.6852.2919.21177.26340L8.18122.9453.2041.83175.29341P63.1131.82176.81

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. *in vitro* phosphorylation {#s0015}
-------------------------------

Unlabeled and doubly ^15^N,^13^C- labeled NS5A-D2 samples (from JFH1 HCV isolate, genotype 2a) were recombinantly produced in *E. coli* and then purified as described by Hanoulle et al. [@bib12] and Dujardin et al. [@bib14].

In a 1 ml assay, a ^15^N,^13^C-NS5A-D2 sample (140 µM) was mixed with CKII (1000 units, purchased from New England Biolabs) and 1.4 mM ATP in a buffer containing 50 mM Tris-Cl pH (7.5), 10 mM MgCl~2~, 0.1 mM EDTA, 2 mM DTT, 0.01% Brij 35. The mixture was incubated at 30 °C for 6 h. Then the buffer was exchanged using a NAP-10 column (GE Healthcare) equilibrated in 20 mM sodium phosphate buffer (pH 6.4), 30 mM NaCl, 1 mM THP, 0.02% NaN~3~ and 5% D~2~O. The phosphorylated NS5A-D2_CKII sample was concentrated up to 250 µM with a Vivaspin2 concentrator (cutoff 5 kDa). After filtration at 0.2 µm, NS5A-D2_CKII aliquots were stored at −80 °C until analyzed. Both the original NS5A-D2 and the final NS5A-D2_CKII protein samples were analyzed by SDS-PAGE on a 15% gel ([Fig. 1](#f0005){ref-type="fig"}).

2.2. Circular dichroism analysis {#s0020}
--------------------------------

NS5A-D2 (7.3 µM) and NS5A-D2_CKII (6.4 µM) samples were analyzed at 293 K in a 1 mm-path length quartz cell using a Jobin Yvon-SPEX-Horiba model CD6 spectropolarimeter. Spectra were acquired with a step of 0.5 nm from 190 to 260 nm and an integration time of 2 s. Blank runs (with buffer only) were made before each measurement and were subtracted from the sample runs to obtain the final spectra ([Fig. 2](#f0010){ref-type="fig"}). UV intensities were expressed as the specific ellipticity per residue (per decimole of amino acid residue). Protein concentrations were determined by UV absorbance at 280 nm (molar extinction coefficient of 15595 M^−1^ cm^−1^). The CD spectrum of NS5A-D2_CKII is characteristic of mainly disordered protein with a large negative peak around 200 nm. Compared to the CD spectrum of NS5A-D2 (unphosphorylated), the only significant difference is that the negative contribution around 200 nm is slightly less pronounced.

2.3. NMR analyses {#s0025}
-----------------

NMR data were acquired on a Bruker AvanceIII 800 MHz spectrometer equipped with a 5 mm TXI room-temperature probe using a Shigemi tube (sample volume 350 µL) at 298 K. Proton chemical shifts were referenced using the methyl signal of sodium 3-trimethylsilyl-\[2,2,3,3-d~4~\]propionate at 0 ppm. Data were acquired with Topspin2.1 software (Bruker).

All NMR datasets were collected on a single 250 µM doubly ^15^N,^13^C-labeled NS5A-D2_CKII sample in 20 mM sodium phosphate buffer (pH 6.4), 30 mM NaCl, 1 mM THP, 0.02% NaN~3~ and 5% D~2~O.

The NMR spectra collected are:--2D ^1^H,^15^N-HSQC spectrum, 4 scans;--3D ^1^H,^15^N,^13^C HNCACB, 8 scans;--3D ^1^H,^15^N,^13^C HNCOCACB, 8 scans;--3D ^1^H,^15^N,^13^C HNCO, 4 scans;--3D ^1^H,^15^N,^13^C HNCACO, 8 scans.

### 2.3.1. Assignments {#s0030}

NMR spectra were processed with the Topspin3.2 software package (Bruker). ^1^H, ^15^N and ^13^C chemical shift assignments of NS5A-D2_CKII were performed with the product plane method developed in-house [@bib15], using the complete NMR dataset mentioned above. The NMR data, analyzed with the software NMRFAM-SPARKY [@bib16], showed that the residue serine 288 (S288) in NS5A-D2 is phosphorylated by CKII *in vitro* ([Table 1](#t0005){ref-type="table"} and [Fig. 3](#f0015){ref-type="fig"}). Backbone assignments of NS5A-D2_CKII have been deposited in the Biological Magnetic Resonance Data Bank (BMRB ID: 27270).

### 2.3.2. Chemical shifts perturbation analysis {#s0035}

The chemical shifts of NS5A-D2_CKII reported in this article (BMRB ID: [27270](mgi:27270){#ir0025}) were compared with those of NS5A-D2 (Biological Magnetic Resonance Data Bank entry 16165) [@bib12]. The ^1^H,^15^N combined chemical shift perturbations (CSP) were calculated using the following formula: *CSP* = √(((ΔδH)^2^ + (ΔδNH/10)^2^)/2) (adapted for IDP from [@bib17]), where ΔδH and ΔδNH correspond to the chemical shift perturbations in the ^1^H and ^15^N dimension, respectively. The CSP values are illustrated in [Fig. 4](#f0020){ref-type="fig"}. The residue with the highest CSP value (0.324 ppm) corresponds to the serine 288 which is phosphorylated in the NS5A-D2_CKII sample. The other residues that exhibit CSP values larger than 0.15 ppm are mainly located around the phosphorylation site and correspond to the NS5A-D2 region encompassing residues 285--291, but also include the T249 and the W312 residues.

### 2.3.3. Secondary Structure Propensity analysis {#s0040}

Experimental ^13^C chemical shifts of ^13^Cα and ^13^Cβ nuclei of NS5A-D2_CKII were analyzed with the Secondary Structure Propensity (SSP) software [@bib18] to calculate a score illustrating structural propensity for each NS5A-D2_CKII residue. The plot of the SSP data along the NS5A-D2 sequence is shown in [Fig. 5](#f0025){ref-type="fig"}. SSP scores close to 0 correspond to fully disordered residues, whereas positive and negative scores represent helical propensities and extended regions, respectively. The low SSP scores in [Fig. 5](#f0025){ref-type="fig"} show that even in the presence of the pS288, NS5A-D2 is still mainly disordered with two main regions exhibiting partial alpha-helical structuration (residues 252--261 and 295--299) and two others showing partial extended conformation (residues 279--288 and 306--308). SSP values of NS5A-D2_CKII were then compared with those obtained from the unphosphorylated NS5A-D2 sample that we have previously reported [@bib13]. Overall, SSP data in the absence and in the presence of the phosphorylation at position 288 are very similar. Only subtle differences were detected in three NS5A-D2 regions: directly around the phosphorylation site (residues 282--287), in the region of residues 271--278, and in residues 301--304 ([Fig. 5](#f0025){ref-type="fig"}). Just prior to the pS288 site (residues 282--287) the propensity to adopt an extended conformation is slightly higher than in the absence of phosphorylation. This is probably due to charge repulsion phenomena between the negatively charged phosphate moiety of pS288 and the carboxyl groups in the side chains of E285, E286 and E287. In the region of residues 271--278, NS5A-D2_CKII seems to be more flexible when phosphorylated, as illustrated by SSP scores close to 0. In residues 301--304, the SSP scores shift from low positive to low negative values, showing a slight change in the conformation of this region upon phosphorylation.
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HCV: Hepatitis C Virus; HSQC: heteronuclear single-quantum coherence; NS5A: nonstructural protein 5A; NS5A-D2: domain 2 of the nonstructural protein 5A; CKII: Casein kinase II, NS5A-D2_CKII: NS5A-D2 phosphorylated by CKII; CSP: combined chemical shift perturbations; THP: (Tris(hydroxypropyl)phosphine).
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